Affordable Access

deepdyve-link
Publisher Website

Preoperative risk score accuracy confirmed in a modern ruptured abdominal aortic aneurysm experience.

Authors
  • Hemingway, Jake F1
  • French, Bryce1
  • Caps, Michael2
  • Benyakorn, Thoetphum3
  • Quiroga, Elina1
  • Tran, Nam1
  • Singh, Niten1
  • Starnes, Benjamin W4
  • 1 Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, Wash.
  • 2 Division of Vascular Surgery, Department of Surgery, Kaiser Permanente, Honolulu, Hawaii.
  • 3 Division of Vascular Surgery, Department of Surgery, Thammasat University, Pathum-Thani, Thailand. , (Thailand)
  • 4 Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, Wash. Electronic address: [email protected]
Type
Published Article
Journal
Journal of vascular surgery
Publication Date
Nov 01, 2021
Volume
74
Issue
5
Pages
1508–1518
Identifiers
DOI: 10.1016/j.jvs.2021.04.043
PMID: 33957228
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Various risk score calculators used to predict 30-day mortality after treatment of ruptured abdominal aortic aneurysms (rAAAs) have produced mixed results regarding their usefulness and reproducibility. We prospectively validated the accuracy of our preoperative scoring system in a modern cohort of patients with rAAAs. A retrospective review of all patients wiith rAAAs who had presented to a single academic center from January 2002 to December 2018 was performed. The patients were divided into three cohorts according to when the institutional practice changes had occurred: the pre-endovascular aneurysm repair (EVAR) era (January 2002 to July 2007), the pre-Harbor View risk score era (August 2007 to October 2013), and the modern era (November 2013 to December 2018). The primary outcome measure was 30-day mortality. Our preoperative risk score assigns 1 point for each of the following: age >76 years, pH <7.2, creatinine >2 mg/dL, and any episode of hypotension (systolic blood pressure <70 mm Hg). The previously reported mortality from a retrospective analysis of the first two cohorts was 22% for 1 point, 69% for 2 points, 78% for 3 points, and 100% for 4 points. The goal of the present study was to prospectively validate the Harborview scoring system in the modern era. During the 17-year study period, 417 patients with rAAAs were treated at our institution. Of the 118 patients treated in the modern era, 45 (38.1%) had undergone open aneurysm repair (OAR), 61 (51.7%) had undergone EVAR, and 12 (10.2%) had received comfort measures only. Excluding the 12 patients without aneurysm repair, we found a statistically significant linear trend between the preoperative risk score and subsequent 30-day mortality for all patients combined (P < .0001), for OAR patients alone (P = .0003), and for EVAR patients alone (P < .0001). After adjustment for the Harborview risk score, the 30-day mortality was 41.3% vs 31.6% after OAR vs EVAR, respectively (P = .2). For all repairs, the 30-day mortality was 14.6% for a score of 0, 35.7% for a score of 1, 68.4% for a score of 2, and 100% for a score of 3 or 4. Our results, representing one of the largest modern series of rAAAs treated at a single institution, have confirmed the accuracy of a simple 4-point preoperative risk score in predicting 30-day mortality in the modern rAAA patient. Such tools should be used when discussing the treatment options with referring physicians, patients, and their family members to help guide transfer and treatment decision-making. Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Report this publication

Statistics

Seen <100 times